Supha Pharmachem Limited (BOM:539561)
0.8500
0.00 (0.00%)
At close: Jan 21, 2026
Supha Pharmachem Revenue
Supha Pharmachem had revenue of 1.11B INR in the quarter ending September 30, 2025, with 342.79% growth. This brings the company's revenue in the last twelve months to 5.27B, down -84.25% year-over-year. In the fiscal year ending March 31, 2025, Supha Pharmachem had annual revenue of 4.05B, down -89.97%.
Revenue (ttm)
5.27B
Revenue Growth
-84.25%
P/S Ratio
0.07
Revenue / Employee
752.71M
Employees
7
Market Cap
342.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.05B | -36.36B | -89.97% |
| Mar 31, 2024 | 40.42B | 35.32B | 692.75% |
| Mar 31, 2023 | 5.10B | 50.45M | 1.00% |
| Mar 31, 2022 | 5.05B | 4.15B | 460.66% |
| Mar 31, 2021 | 900.36M | 871.46M | 3,015.21% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Resonance Specialties | 852.48M |
| Tyche Industries | 570.25M |
| Vasundhara Rasayans | 329.60M |
| Krebs Biochemicals & Industries | 272.16M |
| Link Pharma Chem | 258.97M |
| Crestchem | 242.52M |
| Auro Laboratories | 221.88M |
| Ishita Drugs and Industries | 171.64M |
Supha Pharmachem News
- 2 months ago - Remedium Lifecare strengthens leadership for next-phase growth - Business Upturn